Privé, B. M., Janssen, M. J. R., Oort, I. M. v., Muselaers, C. H. J., Jonker, M. A., Gemert, W. A. v., . . . Nagarajah, J. (2021). Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: The BULLSEYE trial. BMC.
Chicago Style (17th ed.) CitationPrivé, Bastiaan M., et al. Update to a Randomized Controlled Trial of Lutetium-177-PSMA in Oligo-metastatic Hormone-sensitive Prostate Cancer: The BULLSEYE Trial. BMC, 2021.
MLA (8th ed.) CitationPrivé, Bastiaan M., et al. Update to a Randomized Controlled Trial of Lutetium-177-PSMA in Oligo-metastatic Hormone-sensitive Prostate Cancer: The BULLSEYE Trial. BMC, 2021.
Warning: These citations may not always be 100% accurate.